{
  "symbol": "HOLX",
  "name": "Hologic",
  "sector": "Health Care",
  "industry": "Health Care Equipment",
  "date_added": "2016-03-30",
  "headquarters": "Marlborough, Massachusetts",
  "founded": "1985",
  "market_cap": 14462.640128,
  "pe_ratio": 27.268908,
  "forward_pe": 13.750001,
  "eps": 2.38,
  "revenue": 4026.500096,
  "profit_margin": 0.13826,
  "debt_to_equity": 54.799,
  "return_on_equity": 0.11766,
  "dividend_yield": null,
  "current_price": 64.9000015258789,
  "year_high": 84.66999816894531,
  "year_low": 51.900001525878906,
  "price_change_1d": 0.0,
  "price_change_1w": -0.6581972954597104,
  "price_change_1m": 2.9015408909298994,
  "description": "Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal ",
  "website": "https://www.hologic.com",
  "employees": 7063,
  "exchange": "NMS",
  "currency": "USD",
  "analyst_target_price": 67.27467,
  "recommendation": 2.55,
  "number_of_analysts": 15,
  "earnings_history": [],
  "analyst_data": {
    "target_high": 73.0,
    "target_low": 60.0,
    "target_mean": 67.27467,
    "target_median": 70.0
  },
  "last_updated": "2025-07-09T11:23:04.601566",
  "data_quality": {
    "has_financial_data": true,
    "has_earnings_data": false,
    "has_analyst_data": true,
    "completeness_score": 0.6666666666666666
  }
}